Jason Edwards
Radiation Oncology · Chesterfield, MONPI 1568721454
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $3,750 of the $5,399 with a category attached, or 69.5%. Tactile Systems Technology Inc accounts for 77.1% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2021 at $3,890 and has fallen 97.3% since, to $104 in 2025.
Across 34 payments — averaging $158.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tactile Systems Technology Inc$4K
- Koya Medical, Inc.$503
- GT Medical Technologies, Inc$211
- AstraZeneca$127
- Medtronic$122
- Siemens Medical Solutions USA, Inc.$105
- plus $166 from 5 others
What the payments were for
- Speaking & faculty fees$3,75069%
- Food & beverage$1,64931%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tactile Systems Technology Inc | 14 | $4,165 |
| Koya Medical, Inc. | 2 | $503 |
| GT Medical Technologies, Inc | 4 | $211 |
| AstraZeneca | 6 | $127 |
| Medtronic | 1 | $122 |
| Siemens Medical Solutions USA, Inc. | 1 | $105 |
| Visionrt, Inc. | 1 | $54 |
| Novartis | 2 | $50 |
| Novocure Inc. | 1 | $23 |
| Bayer | 1 | $20 |
| Sanofi | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENTRE$3,990
- Flexitouch Plus$3,884
- Dayspring Controller$503
- LEG GARMENT, DAYSPRING, STANDARD$503
- Arm Garmet, Dayspring, Medium$503
- LOWER LEG GARMENT, DAYSPRING$503
- OSTEOCOOL RF ABLATION$122
- GammaTile$107
- FLEXITOUCH$106
- ACTITOUCH$106
- TrueBeam$105
How this compares
$5,399 in reported general payments places this provider in the 80th percentile of 123 radiation oncology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sucralfate | 11 | $1,550 |
| Tamsulosin Hcl | 20 | $285 |
| Gabapentin | 15 | $238 |
| Oxycodone Hcl | 20 | $229 |
| Levothyroxine Sodium | 19 | $223 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 12 | $120 |
| Prochlorperazine Maleate | 15 | $100 |
| Triamcinolone Acetonide | 11 | $69 |
| Silver Sulfadiazine | 12 | $53 |
| Citalopram HbrCitalopram Hydrobromide | 18 | $32 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Chesterfield
- Clifford RobinsonSaint Louis$817K
- Carlos PerezSpringfield$103K
- Pamela SamsonSaint Louis$95K
- Jeffrey BradleySaint Louis$75K
- Christopher SpencerRolla$70K
- Matthew SprakerSaint Louis$61K
- Lauren HenkeSaint Louis$45K
- Jeff MichalskiSaint Louis$44K
- Gregory BiedermannColumbia$41K
- Sunpreet RakhraKansas City$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.